Search Orphan Drug Designations and Approvals
-
| Generic Name: | Autologous Cytokine-Induced Killer Cells (Cytokine-Induced Killer Cells Plus Cytotoxic T Lymphocytes) |
|---|---|
| Date Designated: | 08/01/2018 |
| Orphan Designation: | Treatment of glioblastoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Green Cross Cell Corporation 4, 6th floor, SJ Technovile 278 Beotkkot-ro, Geumcheon-gu Seoul, Seoul South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







